Opportunity ID: 355017

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-24-029
Funding Opportunity Title: Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 18, 2024
Last Updated Date: Jun 18, 2024
Original Closing Date for Applications: Oct 09, 2024
Current Closing Date for Applications: Oct 09, 2024
Archive Date: Nov 14, 2024
Estimated Total Program Funding:
Award Ceiling: $750,000
Award Floor:

Eligibility

Eligible Applicants: State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Private institutions of higher education
City or township governments
Small businesses
Independent school districts
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this notice of funding opportunity (NOFO) is to support basic and applied research to define the mechanisms for establishing, developing and maintaining immunity to HIV in early life (from birth to less than 12 years of age), including the impact of prophylactic vaccination and broadly neutralizing HIV antibodies (bNAbs) to protect against acquisition of HIV infection.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-029.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 355017 Full Announcement-RFA-AI-24-029 -> RFA-AI-24-029-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00287083 Sep 09, 2024 Oct 09, 2024 View

Package 1

Mandatory forms

355017 RR_SF424_5_0-5.0.pdf

355017 PHS398_CoverPageSupplement_5_0-5.0.pdf

355017 RR_OtherProjectInfo_1_4-1.4.pdf

355017 PerformanceSite_4_0-4.0.pdf

355017 RR_KeyPersonExpanded_4_0-4.0.pdf

355017 PHS398_ResearchPlan_5_0-5.0.pdf

355017 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

355017 RR_Budget_3_0-3.0.pdf

355017 RR_SubawardBudget30_3_0-3.0.pdf

355017 PHS398_ModularBudget_1_2-1.2.pdf

355017 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T18:50:37-05:00

Share This Post, Choose Your Platform!

About the Author: